iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Free Report) was the target of a large drop in short interest during the month of June. As of June 15th, there was short interest totaling 22,477 shares, a drop of 45.3% from the May 31st total of 41,071 shares. Based on an average daily volume of 28,094 shares, the short-interest ratio is currently 0.8 days. Currently, 0.4% of the company’s shares are sold short.
Institutional Trading of iShares Genomics Immunology and Healthcare ETF
An institutional investor recently raised its position in iShares Genomics Immunology and Healthcare ETF stock. Ameriprise Financial Inc. increased its position in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Free Report) by 8.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 71,473 shares of the company’s stock after acquiring an additional 5,540 shares during the quarter. Ameriprise Financial Inc. owned about 1.42% of iShares Genomics Immunology and Healthcare ETF worth $1,688,000 as of its most recent SEC filing.
iShares Genomics Immunology and Healthcare ETF Stock Down 0.4%
Shares of iShares Genomics Immunology and Healthcare ETF stock traded down $0.14 during trading on Wednesday, reaching $33.61. 131,184 shares of the company were exchanged, compared to its average volume of 43,202. The business has a 50-day moving average price of $30.03 and a 200-day moving average price of $29.16. The firm has a market capitalization of $183.17 million, a price-to-earnings ratio of 14.76 and a beta of 0.96. iShares Genomics Immunology and Healthcare ETF has a twelve month low of $20.56 and a twelve month high of $33.95.
About iShares Genomics Immunology and Healthcare ETF
The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.
Read More
- Five stocks we like better than iShares Genomics Immunology and Healthcare ETF
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for iShares Genomics Immunology and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Genomics Immunology and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
